Related Experiment Video
Updated: Aug 27, 2025
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Hypersensitivity and in-stent restenosis in coronary stent materials
1Department of Heart Center, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China.
Insights
Hypersensitivity reactions to drug-eluting stent components may cause in-stent restenosis (ISR), a complication of percutaneous transluminal coronary intervention (PCI) for coronary heart disease (CHD). Understanding this link is crucial for improving patient outcomes after PCI.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biomaterials Science
Background:
- Coronary heart disease (CHD) is a leading cause of global mortality.
- Percutaneous transluminal coronary intervention (PCI) is a primary treatment for CHD.
- In-stent restenosis (ISR) remains a significant complication following PCI, impacting patient prognosis.
Purpose of the Study:
- To explore the relationship between hypersensitivity reactions and ISR after PCI.
- To investigate the potential role of drug-eluting stent (DES) components in inducing hypersensitivity.
- To discuss the pathogenesis, influencing factors, and clinical significance of ISR related to hypersensitivity.
Main Methods:
- Review of existing literature on ISR, PCI, and DES.
- Analysis of proposed mechanisms linking hypersensitivity to neointima formation.
- Discussion of clinical observations and potential contributing factors.
Main Results:
- Hypersensitivity reactions to metallic and polymer components of DES are implicated in ISR.
- These reactions can lead to local inflammation and neointima hyperplasia.
- While DES have reduced ISR rates, hypersensitivity remains a concern.
Conclusions:
- Hypersensitivity to DES components is a potential driver of ISR.
- Further research is needed to fully elucidate the pathogenesis and identify preventative strategies.
- Managing hypersensitivity may improve long-term outcomes for patients undergoing PCI for CHD.
Abstract:
Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality rate worldwide. Percutaneous transluminal coronary intervention (PCI) is the most effective method for treating CHD. However, in-stent restenosis (ISR), a long-term complication after PCI, affects the prognosis of patients with CHD. Previous studies have suggested that hypersensitivity reactions induced by metallic components may be one of the reasons of this complication. With the emergence of first- and second-generation drug-eluting stents (DES), the efficacy and prognosis of patients with CHD have greatly improved, and the incidence of ISR has gradually decreased to less than 10%. Nevertheless, DES components have been reported to induce hypersensitivity reactions, either individually or synergistically, and cause local inflammation and neointima formation, leading to long-term adverse cardiovascular events. In this article, we described the relationship between ISR and hypersensitivity from different perspectives, including its possible pathogenesis, and discussed their potential influencing factors and clinical significance.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:30Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:27Angina II: Classification